4人のウォール街のアナリストによると、Envoy Medical Incの収益見積もりは$105.0Kから$58.8Kの範囲です。
Envoy Medical Incの収益品質スコアはどれくらいですか?
Envoy Medical Incの収益品質スコアはB-/26.209646です。このスコアは、収益性、成長、キャッシュ生成と資本配分、レバレッジの4つの次元に基づいています。
Envoy Medical Incはいつ収益を報告しますか?
Envoy Medical Incの次の収益報告は2026-10-29に予定されています
Envoy Medical Incの予想収益はいくらですか?
ウォール街のアナリストによると、Envoy Medical Incの予想収益は$81.59Kです。
Envoy Medical Incは収益予想を上回りましたか?
Envoy Medical Incの最近の収益は$で、予想を。
主要データ
前終値
$0.735
始値
$0.74
当日レンジ
$0.72 - $0.77
52週レンジ
$0.3625 - $1.89
取引高
62.8K
平均取引高
314.7K
配当利回り
3.47%
1株当たり利益(TTM)
-0.86
時価総額
$56.8M
COCHとは何ですか?
Envoy Medical, Inc. is a hearing health company, which engages in providing medical technologies across the hearing loss spectrum. The company is headquartered in White Bear Lake, Minnesota and currently employs 43 full-time employees. The company went IPO on 2021-03-02. The firm is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.